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Though damage caused by radiation has been the focus of rigorous research, the mechanisms through which radiation exerts
harmful effects on cells are complex and not well-understood. In particular, the influence of low dose radiation exposure on
the regulation of genes and pathways remains unclear. In an attempt to investigate the molecular alterations induced by varying
doses of radiation, a genome-wide expression analysis was conducted. Peripheral blood mononuclear cells were collected from
five participants and each sample was subjected to 0.5Gy, 1 Gy, 2.5 Gy, and 5Gy of cobalt 60 radiation, followed by array-
based expression profiling. Gene set enrichment analysis indicated that the immune system and cancer development pathways
appeared to be the major affected targets by radiation exposure. Therefore, 1 Gy radioactive exposure seemed to be a critical
threshold dosage. In fact, after 1 Gy radiation exposure, expression levels of several genes including FADD, TNFRSF10B, TNFRSF8,
TNFRSF10A, TNFSF10, TNFSF8, CASP1, and CASP4 that are associated with carcinogenesis and metabolic disorders showed
significant alterations. Our results suggest that exposure to low-dose radiation may elicit changes in metabolic and immune
pathways, potentially increasing the risk of immune dysfunctions and metabolic disorders.
1. Introduction
In contrast to the hazards of high-dose radiation exposure,
the damage effects of low-dose radiation are not well-
understood yet [1, 2]. Such information is necessary in order
of establish regulatory procedures of radiation protection.
The United Nations Scientific Committee on the Effects of
Atomic Radiation (UNSCEAR) defined 200mSv as low, 200–
2000mSv as medium, and over 2000mSv as high dose [3].
No longitudinal epidemiological investigation has yet been
performed and no direct evidences of damage induced by
low-dose radiation exposure have been found [4]. Therefore,
the International Commission on Radiological Protection
(ICRP) for radiation safety made a conservative assumption:
the linear, nonthreshold (LNT) hypothesis—any long-term,
biological damage caused by ionizing radiation (usually
cancer) is directly correlated with the radiation exposure,
without taking into consideration the possibility that varia-
tions in radiation dosagesmay generate different effects [5–7].
As such, all radiation dosages, whether high or low, are always
considered harmful. There are essentially no well-established
safety thresholds.
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Existing radiation injury studies have primarily focused
on changes in the immune system and progression towards
carcinogenesis as a result of radiation exposure. Immune
system responses can be influenced by variations in the
genes and environment, which includes biological factors like
pathogens and external factors such as ionizing radiation [8,
9]. High-dose radiation (>1 Gy) has been shown to severely
disrupt immune system functions, leading to a drastic
increase in the death of blood cells in mice [10, 11]. Moreover,
in patients with acute radiation syndrome, hematopoietic cell
proliferation was found to be inhibited by radiation exposure
[12]. These findings indicate that high-dose radiation has a
destructive effect on the immune system.However, the extent
to which radiation dose <1 Gy can affect the immune system
is still not clear. Previous studies have shown that damage
to the hematopoietic system and immune system is reduced
at low ionizing radiation doses [13, 14]. In fact, long-term
accumulative radiation dose (<1 Gy) appears to enhance the
resilience and tolerance of cells. It was observed that, under
such a condition, even though T lymphocyte proliferation
was inhibited, the innate immune system and naive T cell
differentiation were activated and immune functions were
enhanced, while the activity andmaturation of dendritic cells
were unaffected [9, 15, 16]. These findings also suggest that
sensitivity and tolerance to radiation are different among the
variety of immune cells in the body.
The association between low-dose radiation and carcino-
genesis is controversial. However, some studies have provided
evidence to support the ability of low-dose radiation to
suppress the aging process, delay cancer progression, enhance
immune functions, and promote growth and development
[17]. A multistage cancer model was used to describe the
putative rate-limiting steps in carcinogenesis in association
with radiation hormesis, suggesting a positive impact of
radiation therapy on the incidence of lung cancer and the
potential benefit of low-dose radiation stimulus on enhancing
DNA repair and reducing carcinogenesis risk [18, 19].
Nonetheless, very few existing studies have fully demon-
strated the effects of low-dose radiation on a genome-wide
scale. Recent gene expression profiling analyses support the
use of biomarkers for the estimation of radiation biodosime-
try [20, 21]. These studies revealed that genes involved in
cellular structural integrity, immune functions, cell cycle
control, and apoptosis were more responsive to radiation. In
particular, alterations in the expression of genes responsible
for the formation and maintenance of cellular structure
and cell cycle control may lead to chromosome instability
and carcinogenesis [22–25]. Unfortunately, changes in the
transcriptome elicited by different radiation dosages have not
been fully investigated.
In the present study, we attempted to examine the
effects of varying doses of cobalt 60 radiation in human
peripheral blood mononuclear cells. By integrating array-
based gene expression profiling with subsequent systematic
bioinformatics analyses, we uncovered radiation sensitive
genes concentrated in certain chromosomal regions, specific
gene expression patterns associated with different radiation
dosages, and important immune and cancer-related pathways
responsive to radiation exposure.
2. Material and Methods
2.1. Sample Preparation. Blood samples (30mL per subject)
are obtained from five participants and collected into vacu-
tainers containing sodium heparin. Samples were irradiated
using 60Co at a dose rate of 0.546Gy/min (The Institute
of Nuclear Energy Research (INER), Taoyuan, Taiwan). The
radiation doses used in these experiments were chosen to
cover a range of doses: 0.5 Gy, 1 Gy, 2.5 Gy, and 5Gy.The con-
trol RNA samples were not exposed to any radiation. Samples
were harvested after 24 hours of treatment with radiation
[26, 27]. Informed consentwas obtained fromall participants.
All procedures were approved by the Institutional Review
Board at Tzu Chi General Hospital, Hualien, Taiwan.
2.2. RNA Preparation. Total RNA was isolated from periph-
eral blood mononuclear cells using Trizol. RNA quality was
determined by an OD260/280 ratio ≥1.8 and OD260/230
ratio ≥1.6 on a spectrophotometer and the intensity of the
18S and 28S rRNA bands on a 1% formaldehyde-agarose gel.
RNA was detected on a spectrophotometer. RNA integrity
was examined on an Agilent 2100 Bioanalyzer (Agilent
Technologies, Inc., USA). RNA samples with a RIN (RNA
integrity number) of ≥6.0 and 18S/28S >0.7 was subjected to
microarray analysis.
2.3. Microarray Data Analysis. One microgram of total RNA
was prepared for the cDNA reversed transcription reaction
and using Amino Allyl MessageAmp II aRNA Amplification
Kit (Ambion number AM1753, CA, USA) according to the
manufacturer’s instructional resources information system.
Double stranded cDNA was synthesized and followed by an
in vitro transcription reaction to amplify aRNA incorporated
with biotin labeling system for the microarray hybridization
in triplicate. The Cy5-labeled aRNAs were fragmented by
using the reagents and protocol provided in Ambion RNA
Fragmentation Reagents kit (Ambion Inc., Austin, TX) for
microarray hybridization to the HumanWhole GenomeOne
Array Version 6.1 (HOA 6.1, Phalanx Biotech Group, Inc.,
Taiwan). Nonspecific binding targets were washed out three
times.
2.4. Statistical Analysis. The arrays were scanned by
AXON4000B scanner (Molecular Devices, CA, USA). The
fluorescent intensities of each spot were analyzed by GenePix
4 (Molecular Device, CA, USA).The data were averaged from
the triplicates and were normalized using Rosetta Resolver
System software (Rosetta Biosoftware, USA). Rosetta error
models were available for gene expression analysis in
five pairwise comparisons. Standard selection criteria to
identify differentially expressed genes are as follows: (1)
log
2
|Fold change| ≥ 1 and 𝑃 < 0.05; (2) log
2
ratios = “NA”
and the differences of intensity between the two samples
≥1000. Calculation of reproducibility among the technical
replicates was performed by Pearson’s correlation coefficient.
PCA and clustering analysis were performed on selected
differentially expressed gene lists after data transformation
and mean centering to cluster genes by averagely linkage
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algorithm. The correlation of expression profiles between
samples and treatment conditions was demonstrated by
unsupervised hierarchical clustering analysis.
2.5. Bioinformatics Analysis. Differentially expressed genes
were used as input for a series of bioinformatics analyses
performed with the WEB-based GEne SeT AnaLysis Toolkit
(WebGestalt) [28, 29]. WebGestalt is an open analytical
platform that integrates gene ontology (GO) [30], KEGG [31],
WikiPathway [32], protein interaction networks, microRNA
binding sites, and transcription factor targets [MSigDB [33]],
as well as cytogenetic band information, for a variety of
enrichment analyses. The GO, KEGG, protein interaction
network, and cytogenetic band enrichment analytical tools
were utilized to analyze the differentially expressed genes.
Multiple testing bias was adjusted by a Benjamini-Hochberg
threshold of 𝑃 < 0.05, except for the smaller number of
differentially expressed genes in the 0.5 Gy dosage group,
where a raw 𝑃 value of > 0.01 was applied as the threshold.
3. Results
3.1. Differentially Expressed Genes (DEGs) Profile Exhib-
ited after Different Exposure Doses of Radiation. Principle
component analysis (PCA) was performed to evaluate any
differences among biological replicates and their treatment
conditions. Data reproducibility was assessed by PCA and
clustering analysis shown in Supplemental Figures 1 and 2,
available online at http://dx.doi.org/10.1155/2014/834087.The
analysis result indicated the experiment of microarray was
consistent.
Table 1 shows the number of significantly differentially
expressed genes in human PBMC exposed to varying doses of
60Co radiation (absolute Log
2
ratio ≥1; absolute fold-change
≥2; FDR < 0.05). A radiation dosage of 0.5 Gy did not affect
a lot of genes; therefore, this dose probably induces subtle
changes in the genome relative to other radiation dosages.
In contrast, 1 Gy of radiation dose generated changes in
the greatest number of genes; therefore, this must be an
important dose. From 1Gy to 2.5 Gy, there is a drop in the
number of genes affected by radiation, but from 2.5Gy to
5Gy, there appears to be an opposite trend, suggesting that
there are complex regulatory mechanisms underlying these
dosage levels (see Figure 1).
3.2. Pathway Analysis. Gene ontology enrichment analysis
results are given in Table 2 and Supplementary Table 1.
It appears that, starting at a dosage of 0.5 Gy 60Co radi-
ation, cells may have already been affected in terms of
nucleotide metabolism and signaling pathways responsive to
external apoptotic signals. Most of the genes responsive to
1 Gy of 60Co radiation dosage are members of the immune
system and programmed cell death. At higher radiation
dosages (2.5 Gy and 5Gy), negative regulation of molecular
functions was activated, cell’s response to cytokine stimulus
was changed, and genes involved in the cytokine-mediated
pathway were altered.
Table 1: Number of total differentially expressed genes.
Comparison (Gy) Upregulated genes Downregulated genes
0 versus 0.5 13 41
0 versus 1 430 398
0 versus 2.5 111 76
0 versus 5 106 299
Standard selection criteria to identify differentially expressed genes are as
follows: (1) log
2
|Fold change| ≥ 1 and 𝑃 < 0.05; (2) log
2
ratios = “NA” and
the differences of intensity between the two samples (duplicated chip) ≥1000
was excluded.
Table 3 indicates that different cellular pathways are
affected at the various radiation dosages tested in this
study. At the radiation dosages (0.5 and 1Gy), most of the
genes affected belong to metabolism and maintenance of
regular cell activity in the blood. In contrast, high dosages
of radiation significantly altered the genes involved in the
MAPK signaling pathway, cell’s response to cytotoxicity, and
apoptosis.
At 0.5 Gy, the biological processes most affected appeared
to be nucleotidemetabolism, indicating that radiation dosage
may alter basal cellular processes. Beginning at 1 Gy, increas-
ing radiation exposure induces changes in a significant
number of genes involved in the immune system processes
and programmed cell death pathways.These genes aremostly
mapped to chromosomes 2, 11, 16, 17, and 19 (Supplementary
Table 2). It is likely that these chromosomes are partic-
ularly sensitive to radiation-induced damage. Most of the
genes affected by 60Co radiation, regardless of the dosage,
appeared to be enriched on chromosomes 11, 17, 19, 16, and
2. Interestingly, chromosome 11 contains the most number
of genes whose expression levels were altered by the 1 Gy
dosage of radiation, suggesting that this chromosome may
be particularly sensitive to 60Co radiation. It is possible that
these genes located on chromosome 11 are associated with
the cell’s response to radiation-induced apoptotic signals. We
selected these genes for a protein-protein interaction network
analysis and categorized the resulting network modules
according to their corresponding gene ontologies.The poten-
tial relationships among the differentially expressed genes
located on chromosome 11 are illustrated in Supplemental
Figure 3. Indeed, these genes (FADD,DAK,RARRES3, FUT4,
CD44, and CASP1) have functions related to cell death and
appear to be involved in cell defense mechanisms.
3.3. Disease Associations with DEGs. Even though genes
affected by 0.5Gy of radiation treatment are mostly involved
in metabolism, changes in these genes have been associated
with various cancers and immune system diseases. It is pos-
sible that alterations in basal cellular processes may play an
important role in the development of cancer or modulate the
risk of cancer. Viral infections are associated with the changes
in gene expression across the various radiation dosages
tested. This suggests that radiation exposure may weaken the
immune defense, increasing the cell’s susceptibility to viral
attacks (Table 4).
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Table 2: Top three most enriched biological processes of genes differentially expressed in human peripheral blood mononuclear cells when
exposed to varying doses of 60Co radiation according to the gene ontology enrichment analysis.
Dose GO ID Biological process 𝑃 value(BH) Gene symbol
0.5
GO:0045935 Positive regulation of nucleobase-containingcompound metabolic process 0.0012
a SS18, SMARC2, EPAS1, LHX1, ZNF148, KLF6, F2R
GO:0051254 Positive regulation of RNA metabolic process 0.0006a TNSF10, MCL1
GO:2001236 Regulation of extrinsic apoptotic signalingpathway 0.0011
a TNSF10, MCL1
1
GO:0002376 Immune system process 0.0018 109 genesb
GO:0006955 Immune response 0.0213 69 genesb
GO:0012501 Programmed cell death 0.03 88 genesb
2.5
GO:0044092 Negative regulation of molecular function 0.0299
NKX3-1, DUSP6, CDC27, PRDX3, CAST, PSMC2,
BAX, AZIN1, PSMA1, PELI1, CD44, HIPK3,
SERPINB2, PI3, SENP2, RLIM, THBS1
GO:0019221 Cytokine-mediated signaling pathway 0.0299
IL1R1, RANBP2, CCL2, NUP54, CD44, IL1A,
IFNGR1, KLF6, EIF4G2, JAK3, CXCR3,
HLA-DRB5
GO:0071345 Cellular response to cytokine stimulus 0.0299
RANBP2, IL1R1, RANBP2, CCL2, NUP54, CD44,
IL1A, IFNGR1, KLF6, EIF4G2, JAK3, CXCR3,
HLA-DRB5
5
GO:0071310 Cellular response to organic substance 0.009 34 genesb
GO:0019221 Cytokine-mediated signaling pathway 0.0034
USP18, NUP54, IFNAR1, IL1A, CXCR3, EIF4G2,
NUP98, TRADD, SOCS3, NUMBL, RANBP2,
PML, PTPRN, CD44, JAK3, HLA-DRB5,
CAMK2A
GO:0070887 Cellular response to cytokine stimulus 0.0162 37 genesb
aThe raw 𝑃 value for the GO analysis.
bThe gene identities are given in the Supplementary Material 1 along with the rest of the GO enrichment analysis results.
Table 3: Top three most enriched pathways of genes differentially expressed in human peripheral blood mononuclear cells when exposed to
varying doses of 60Co radiation according to KEGG pathway enrichment analysis.
Dose (Gy) KEGG ID Pathway 𝑃 value (BH) Gene symbol
0.5 4610 Complement and coagulation cascades 0.0018 PLAU, F2R
1
1100 Metabolic pathways 2.01𝑒 − 07 48 genesa
3013 RNA transport 7.28𝑒 − 05
RANBP2, EIF1AY, EIF4A2, EIF3E, SUMO3, ELAC2,
EIF5, EIF1B, NUP98, EIF3H, TACC3, CLNS1A, and
SUMO1
620 Pyruvate metabolism 0.0001 ACAT1, MDH1, ACACB, PKM, DLD, HAGHL, andACACA
2.5
4010 MAPK signaling pathway 2.15𝑒 − 06 1L1R1, ELK4, MDUSP6, PLA2G5, MAP4K4,MAP3K8, MAP4K3, PPM1A, IL1A, and PRKACB
4210 Apoptosis 0.0034 1L1R1, 1L1A, PRKACB, and BAX
4640 Hematopoietic cell lineage 0.0034 1L1R1, CD44, IL1A, and HLA-DRB5
5
4120 Ubiquitin mediated proteolysis 0.0007 ANAPC1, PARK2, CDC27, PML, SKP1, SAE1,SYVN1, and SOCS3
4650 Natural killer cell mediated cytotoxicity 0.0034 PIK3R3, TNFRSF10, NRAS, PRKCG, IFNAR1, andTNFRSF10
4080 Neuroactive ligand-receptor interaction 0.0065 HTR7, SSTR5, GABRB2, TAAR9, S1PR2, GHRHR,TAAR5, CCKAR, and VIPR2
aThe gene identities are given in the Supplementary Material 2 along with the rest of the KEGG pathway enrichment analysis results.
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Table 4: Top 10 diseases overrepresented by the differentially expressed genes under the exposure of varying doses of 60Co exposure in human
PBMC.
0.5Gy 1Gy 2.5Gy 5Gy
Glioma HIV Necrosis Neuroblastoma
Carcinoma, small cell Leukemia Hernia Hernia
Neoplasms Viral diseases Viral diseases Hematologic
Cancer or viral infections Cancer or viral infections HIV Peripheral
Carcinoma, hepatocellular Shock Immunologic deficiencysyndromes Necrosis
Liver neoplasms Immunologic deficiencysyndromes Chorioamnionitis
Therapy-related acute myeloid
leukemia (t-ML)
Carcinoma Death Retroviridae infections Connective tissue diseases
Hypercortisolism Sexually transmitted diseases Preterm rupture of membranes Autoimmune diseases
Glioblastoma Lentivirus infections Lentivirus infections Disease susceptibility
Immune system diseases Retroviridae infections Periodontitis Genetic predisposition to disease
All disease associations were filtered by BH-adjusted 𝑃 value <0.05.
Human peripheral blood mononuclear cells
Co60 radiation exposure (0 Gy, 0.5 Gy, 1 Gy, 2.5 Gy, and 5 Gy)
RNA isolation
Gene expression profiling
Identification of differentially expressed genes
Enrichment analysis
GO
KEGG
18 19
Chromosome
and disease
associations
Protein
interaction
network
FADD
TNFRSF8
TNFSF8
TNFRSF10B TNFSF10 CASP4
CASP1
11.3 13.3
13.3
13.4
13.2
13.2
13.1
13.1
12
12
11.2
11.2
12
21
22
23
Figure 1: System flow of our analysis.
3.4. Gene Interaction Network. The genes and the associ-
ated diseases were grouped into broader categories: cancer,
immune system diseases, and cell death for visualization of
the gene interactions involved in modulating the susceptibil-
ity to these cellular abnormalities. This interaction network
was constructed based on coexpression and experimental val-
idation. Figure 2 shows that radiation sensitive genes (FADD,
TNFRSF10B, TNFSF10, TNFRSF8, TNFSF8, TNFRSF10A,
CASP1, and CASP4) located on chromosome 11 not only are
mapped to cancer-, immune system-, and cell death-related
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diseases but also may be directly interacting with each other,
mediating the effects of varying doses of radiation.
4. Discussion
The association between low-dose radiation and carcinogen-
esis remains controversial. In our study, genes responsive
to radiation doses (≤1 Gy) were mostly associated with
metabolism and signal pathway, whereas radiation doses
(>1 Gy) induced expression changes in genes associated with
the immune system response and cytokine signaling pathway,
as well as cytotoxicity and apoptosis. Although medium-
dose radiation could alter the expression of genes involved
in metabolic activities, this observation may not be able to
establish a direct link between radiation hormesis and cell
survival. However, our results suggest that, even at low levels,
radiation is able to modulate cellular processes.
At higher dosage levels, the effect of radiation appeared
to extend to the immune system and cytokine signaling,
inducing changes in cell cycle, proliferation, and cell death,
potentially influencing the risk of cancer development in
immune cells that are sensitive to radiation [34]. In particular,
radiation induces apoptosis in mature T and B lymphocytes
responsible for mediating adaptive immunity, causing lethal
damage to the precursors of monocytes and granulocytes
involved in innate immunity in bone marrow stem cells
[35, 36]. In A-bomb survivors, both mature lymphocytes and
bone marrow stem cells were severely damaged, weakening
the defense of their immune systems against microbial
invasion [37, 38]. As a result, many people died from
infections. Interestingly, bone marrow stem cells were able to
recover from apoptosis induced by infections, suggesting that
damage to innate immunity is temporary following radiation
exposure. A major subset of T lymphocytes responsible
for antigen-specific immunity factors took a long time to
recover with diminished CD4 T-cell numbers and function.
In compensation for the loss of T cells, the number of B cells
is increased in exposed persons [35, 36]. Previous studies also
showed decreased number of CD4 T-cells and rising levels of
inflammatory proteins in A-bomb survivors’ blood samples;
the extent of such changes was age-dependent, indicating
that radiation exposure may accelerate the aging processes
by impairing the immune system. However, as radiation
elicits a wide variety of changes in different immune cells,
it is difficult to evaluate the effect of radiation on immune
system functions.Therefore, there is currently a lack of direct
and clear evidence associating the health conditions with
persistent abnormalities in the T and B lymphocytes caused
by radiation exposure in A-bomb survivors [37, 38]. In our
work, we found pathways related immunity were alteration
after radiation exposure (Figure 2 and Table 4). The results
should provide the putative molecular mechanism involving
the harmful effect of radiation exposure to immune-system
disruption.
In addition, recent studies have reported that mortality
resulting from heart diseases increases with radiation dose
in the Life Span Study cohort of the Radiation Effects
Research Foundation [39]. Metabolic risk factors, such as
hypertension, hypertriglyceridemia, diabetesmellitus, hyper-
cholesterolemia, low high density lipoprotein, and choles-
terol, are common complex diseases and are known to
increase the risk of coronary heart disease (CHD) [40]. In
addition, radiation was found to correlate with visceral fat
syndrome, insulin resistance syndrome, and independence of
age, gender, or BMI [41]. However, the association between
radiation exposure and coronary heart disease (CHD) is
unclear. In Tables 2 and 3 shown, metabolic pathway was
revealed by enrichment analysis. The results indicate that
radiation exposure might enhance the risk to CHD via the
metabolic pathway disruption.
We postulate that 1 Gy may be a critical radiation dosage,
under which many genes showed altered expression level.
Further, at the transcriptome level, the effect of radiation
on gene expression may be dosage dependent. Indeed, we
observe an increasing number of genes being affected by
radiation from 0.5 to 1 Gy dosages. Then, the number of
affected genes declined at 2.5 Gy radiation exposure but
accelerated again after treatment with 5Gy of radiation.
Although a lot of confounding factors (such as smoking,
gender, etc.) have to be considered, epidemiologic evidence
is accumulating to suggest that acute exposure to a radiation
dosage greater than enhances the risk of circulatory disease
for doses higher than 0.5Gy [42–44]. In line with these
observations, we found that, at the 1 Gy radiation dose,
not only was the number of altered genes dramatically
increasing, but also the number of suppressed genes was
greater than the enhanced genes, indicating that cell activity
was decreased. The interaction data noted that some genes
were associated with cancer, immune system, and cell death,
similar to previous studies. These interactions were mapped
to different pathways depending on the radiation dosage.
Specifically, under 1 Gy of radiation exposure, a lot of interact-
ing genes involved in cancer development, immune system,
and cell death responded with changes in expression level.
For example, alteration in TNFRSF10B transcript abundance
may disrupt cell cycle control and induce the development
of carcinogenesis. Changes in genes (PSMA1, 2, 4, 5, and 10)
involved in proteasome activity may affect the immune sys-
tem, diminishing immune defenses and increasing immune
system which was affected through proteasome to decrease
immune defense and make the cells more susceptible to viral
attacks.
From our analysis result in Figure 2, several genes expres-
sions were sensitive to radiation exposure. TNFRSF10B,
TNFRSF10A, and TNFRSF8 are members of the TNF-
receptor superfamily. TNFRSF10A transduces cell death sig-
nal and induces cell apoptosis. In FADD-deficient mice,
studies suggested that FADD is required for the apoptosis
mediated by TNFRSF10A and TNFRSF10B [45]. TNFRSF8
interacts with TRAF2 andTRAF5 tomediate the activation of
NF-𝜅B. TNFRSF8 has been reported to limit the proliferative
potential of autoreactive CD8 effector T cells and against
autoimmunity and positively regulate apoptosis [46]. High-
risk FLT3-ITD mutation of acute myeloid leukemia was
associated with high TNFRSF8 expression on myeloblasts
[47]. TNFSF10/TRAIL is a cytokine belonging to the TNF
ligand family. TNFSF10 induces apoptosis in transformed and
BioMed Research International 7
FADD
TNFRSF8
TNFSF8
TNFRSF10B TNFSF10
TNFSF10
TNFRSF10A
TNFRSF10B
CRKL
RAPGEF1
NFKB2
BCL3
SP110
5 Gy1 Gy0.5 Gy
CASP4
CASP1
POLB
PCNA
EGR1
STK11
TNFRSF10B
SUMO1
EPAS1
VHL
MBD2 IKZF1
SIN3A
IFIT3
AHR
HSP90AA1
HDAC2
ETV6
PRKDC
(a)
PSMB2
PSMA5 PSMD4
PSMD10 PSMA1
PSMC2
1 Gy 2.5 Gy
(b)
FADD
TNFRSF8
TNFSF8
TNFSF10TNFRSF10B
TNFRSF10B
TNFRSF10ACASP1
REL
MAP3K8
CASP4
5 Gy
Coexpression
Experiments
[Homology]
1 Gy 2.5 Gy
(c)
Figure 2: Gene interaction networks specific to the varying doses of 60Co radiation exposure. (a) Gene interactions associated with cancer;
(b) gene interactions associated with immune system diseases; (c) gene interactions associated with cell death.
tumor cells. TNFSF10 binding to its receptors will trigger
the activation of MAPK8/JNK, caspase 8, and caspase 3.
TRAIL mediating calcification of aortic valve interstitial
cells via the apoptosis mechanism has been reported [48].
FADD is an adaptor molecule and mediates cell apoptotic
signal. This protein recruited TNF receptors to initiate the
death signaling. CASP1 and CASP4 are members of the
caspase family. CASP1 activates the inactive precursor of
interleukin-1 involved in inflammasome and induces cell
apoptosis in various development stages [49]. CASP4 cleaves
and activates its own precursor protein and is required for
activation of inflammasome [50]. CASP4 directly activates
caspase 9 in endoplasmic reticulum stress-induced neuronal
apoptosis [51]. From review of above gene/pathway function,
the results indicated carcinogenesis, cell death, and immune
system were sensitive to radiation exposure, especially in
1 Gy.
In conclusion, our array-based expression analysis pro-
filed the changes in gene expression in response to vary-
ing dosages of radiation exposure. Although our findings
require the support from more experimental validations, by
integrating publically available tools to perform a series of
systematic bioinformatics analyses, we were able to identify a
variety of genes involved in metabolism, signaling, immune
system, and disease-associated pathways that are sensitive to
radiation exposure in a dosage-dependent manner. Follow-
up research about the association between these radiation
dosages and metabolic mechanism or carcinogenesis would
be important to address the effect of low-dose radiation on
the development of cancer and metabolic disorders.
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